C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2011
06/30/2011	WO2011079007A1 Crth2 modulators
06/30/2011	WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011	WO2011078312A1 Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient
06/30/2011	WO2011078311A1 Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma
06/30/2011	WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same
06/30/2011	WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
06/30/2011	WO2011077444A1 A new process for the preparation of pure telmisartan
06/30/2011	WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
06/30/2011	WO2011076878A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists
06/30/2011	WO2011076723A1 Amino-heteroaryl derivatives as hcn blockers
06/30/2011	WO2011076674A1 New polyamide, polyimide or polyamide-imide comprising dibenzodiazocine units
06/30/2011	WO2011076086A1 Intermediate compounds of tamiflu, methods of preparation and uses thereof
06/30/2011	WO2011013992A3 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/30/2011	WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
06/30/2011	US20110160452 2-Aminopyrimidine modulators of the histamine H4 receptor
06/30/2011	US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor
06/30/2011	US20110160232 Certain chemical entities and therapeutic uses thereof
06/30/2011	US20110160226 Substituted Triazolo-Pyrimidine Compounds
06/30/2011	US20110160225 Compositions and methods of use for treating or preventing lipid related disorders
06/30/2011	US20110160214 Compositions and methods for eye whitening
06/30/2011	US20110160209 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
06/30/2011	US20110160208 Diaryl-substituted five-membered heterocycle derivative
06/30/2011	US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/30/2011	US20110160206 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
06/30/2011	US20110160203 Substituted Pyrrolo-Aminopyrimidine Compounds
06/30/2011	US20110160197 Substituted Indoles and a Method for the Production and Use Thereof
06/30/2011	US20110160192 Biaryl amino acids and their use in dna binding oligomers
06/30/2011	US20110160187 3-aryl-5,6-disubstituted pyridazines
06/30/2011	US20110160182 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/30/2011	US20110160178 Heterosubstituted n-thiolated beta-lactam compounds and methods of use
06/30/2011	US20110160176 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
06/30/2011	US20110159483 Cyanine compounds, compositions including these compounds and their use in cell analysis
06/30/2011	US20110159019 2,4-diaminopyrimidine compound
06/30/2011	US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
06/30/2011	US20110158930 Method for treatment of irritable bowel syndrome
06/30/2011	US20110155249 Dye for photoelectric conversion device and photoelectric conversion device
06/30/2011	US20110155241 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell
06/30/2011	CA2785409A1 Method for predicting therapeutic effects of chemotherapy on hepatocellular carcinoma patients
06/30/2011	CA2785389A1 Antitumor agent or postoperative adjuvant chemotherapeutic agent for hepatocellular carcinoma treatment
06/30/2011	CA2785353A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists
06/30/2011	CA2785191A1 Crth2 modulators
06/30/2011	CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011	CA2783209A1 Amino-heteroaryl derivatives as hcn blockers
06/29/2011	EP2338493A1 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
06/29/2011	EP2338487A1 Combination therapy with PARP inhibitors
06/29/2011	EP2337781A2 Anti-viral compounds to treat hcv infection
06/29/2011	EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands
06/29/2011	CN1972932B Compounds for treating dyslipidemia
06/29/2011	CN1834090B Benzimidazole compounds, its preparation and uses
06/29/2011	CN102112469A Silent desensitizers of neuronal nAChR and methods of use thereof
06/29/2011	CN102112468A New compounds
06/29/2011	CN102112467A Compounds and compositions as kinase inhibitors
06/29/2011	CN102112466A (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
06/29/2011	CN102112450A 5-alkynyl-pyrimidines
06/29/2011	CN102112449A Phenyl or pyridinyl substituted indazoles derivatives
06/29/2011	CN102112445A Hydroxyphenylsulfonamides as antiapoptotic Bcl inhibitors
06/29/2011	CN102108078A 1,4-substituted phthalazine compound and preparation method and applications thereof
06/28/2011	US7968710 Prokineticin 1 receptor antagonists
06/28/2011	US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/28/2011	US7968591 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments
06/28/2011	US7968559 Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
06/28/2011	US7968551 Chromenoneindoles
06/28/2011	US7968550 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
06/28/2011	US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
06/28/2011	US7968546 Pyridazinone kinase inhibitors
06/28/2011	US7968545 Compositions useful as inhibitors of voltage-gated ion channels
06/28/2011	US7968537 Pyrimidine compound and pests controlling composition containing the same
06/28/2011	US7968215 OLED device with cyclobutene electron injection materials
06/28/2011	CA2649083C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
06/28/2011	CA2645291C Dibenzyl amine derivatives as cetp inhibitors
06/28/2011	CA2614529C Pyridazinone derivatives as thyroid hormone receptor agonists
06/28/2011	CA2508330C Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives
06/28/2011	CA2496241C 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2011	WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	WO2011075634A1 Bicyclic derivatives useful as inhibitors of dpp-1
06/23/2011	WO2011075607A1 Novel inhibitors of hepatitis c virus replication
06/23/2011	WO2011075439A1 Hepatitis c virus inhibitors
06/23/2011	WO2011073487A1 Procedure for the enantioselective addition of organozinc compounds to compounds derived from acetophenones
06/23/2011	WO2011073444A2 Azoline compounds for combating invertebrate pests
06/23/2011	WO2011073376A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
06/23/2011	WO2011073316A1 4-aryl-butane-1,3-diamides
06/23/2011	WO2011073160A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
06/23/2011	WO2011073098A1 1-(heteroaryl)-pyrazol-4-yl-acetic acids, method for the production thereof, and the use thereof as herbicides and plant growth regulators
06/23/2011	WO2011073092A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/23/2011	WO2011072791A1 Sphingosine kinase inhibitors
06/23/2011	WO2011051490A3 Heterocyclic derivatives
06/23/2011	WO2011022508A3 Substituted benzoazepines as toll-like receptor modulators
06/23/2011	WO2011008005A3 Method for preparing histidyl-prolinamide derivatives using a polymer solid phase support
06/23/2011	WO2011004391A3 An improved process for the preparation of eletriptan and its salt thereof
06/23/2011	US20110152797 Prostaglandins and analogues as agents for lowering intraocular pressure
06/23/2011	US20110152533 Prodrugs of inhibitors of plasma kallikrien
06/23/2011	US20110152518 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
06/23/2011	US20110152466 Amide-extended crosslinking compounds and methods for use thereof
06/23/2011	US20110152337 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2011	US20110152321 Bicyclic derivatives useful as inhibitors of dpp-1
06/23/2011	US20110152299 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
06/23/2011	US20110152293 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
06/23/2011	US20110152289 Dimeric derivatives of artemisinin and application in anti-cancer therapy
06/23/2011	US20110152283 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
06/23/2011	US20110152281 Compounds and method for treatment of cancer

1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 626